Back to today’s briefing

Story perspectives

UK Life Sciences Face Supply Chain Crisis, Scotland Thrives

3/14/2025

48 7

Summary

Story summary

In 2025, life sciences companies grapple with supply chain vulnerabilities and soaring R&D costs. The UK's heavy dependence on China for antibiotics raises alarms, yet Scotland's sector flourishes with record turnover and robust investments. To thrive, companies must embrace collaboration and innovation while navigating regulatory hurdles and fierce market competition.

1 of 1

Story summary

In 2025, life sciences companies grapple with supply chain vulnerabilities and soaring R&D costs. The UK's heavy dependence on China for antibiotics raises alarms, yet Scotland's sector flourishes with record turnover and robust investments. To thrive, companies must embrace collaboration and innovation while navigating regulatory hurdles and fierce market competition.